Sex, Brinkman Index, And Pleural Glucose Levels As Predictors Of Pleurodesis Outcome In Malignant Pleural Effusion: Evidence From Rsud Jenderal Ahmad Yani Metro (2023–2024)
DOI:
https://doi.org/10.33533/jpm.v20i1.12348Keywords:
Adenocarcinoma; Brinkman Index; Glucose; Malignant pleural effusion; Pleurodesis; SexAbstract
Malignant pleural effusion (MPE) is a frequent complication of advanced adenocarcinoma, leading to dyspnea and impaired quality of life. Pleurodesis is the standard palliative approach, but outcomes vary. This study evaluated the association of sex, smoking exposure (Brinkman Index), and pleural glucose with pleurodesis success.
An observational analytic study was conducted at RSUD Jenderal Ahmad Yani Metro, Lampung, from July 2023 to July 2024. Thirty-eight patients with adenocarcinoma-related MPE were recruited; six were excluded, leaving 32 eligible subjects who underwent bleomycin pleurodesis. Outcomes were categorized as complete response (CR), partial response (PR), or failure. Associations between predictive factors and pleurodesis outcomes were analyzed using the Chi-Square test.
Pleurodesis success correlated significantly with sex (p = 0.042), Brinkman Index (p = 0.027), and pleural glucose (p < 0.001). Females achieved higher CR rates (53.8%) than males (15.8%). Lower Brinkman Index values were linked to better outcomes, while pleural glucose >60 mg/dL strongly predicted success.
Conclusion: Sex, smoking exposure, and pleural glucose may predict pleurodesis outcomes in adenocarcinoma-related MPE. Female sex, lower smoking burden, and higher pleural glucose were associated with improved pleural adhesion, supporting their role in guiding treatment.
References
Acencio MMP, et al. Evaluation of cellular alterations and inflammatory profile of mesothelial cells and/or neoplastic cells exposed to talc used for pleurodesis. Oncotarget. 2020;11(41):3730–3736. Available from: https://doi.org/10.18632/oncotarget.27750
Alsayed S, et al. Malignant pleural effusion biomarkers as predictor for chemical pleurodesis success. Egypt J Chest Dis Tuberc. 2015;64(1):153–160. Available from: https://doi.org/10.1016/j.ejcdt.2014.08.005
Aydin Y, et al. Malignant pleural effusions: appropriate treatment approaches. Eurasian J Med. 2009;41(3):186–193. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25610100
Bibby AC, et al. ERS/EACTS statement on the management of malignant pleural effusions. Eur Respir J. 2018;52(1):1–23. Available from: https://doi.org/10.1183/13993003.00349-2018
Charalampidis C, et al. Physiology of the pleural space. J Thorac Dis. 2015;7(Suppl 1):S33–S37. Available from: https://doi.org/10.3978/j.issn.2072-1439.2014.12.48
Charalampidis C, et al. Pleura space anatomy. J Thorac Dis. 2015;7(Suppl 1):S27–S32. Available from: https://doi.org/10.3978/j.issn.2072-1439.2015.01.48
Rodriguez-Panadero F, Antony VB. Pleurodesis: State of the art. Eur Respir J. 1997;10(7):1648–1654. Available from: https://doi.org/10.1183/09031936.97.10071648
Divisi D, Crisci R. Malignant pleural effusions. J Xiangya Med. 2021;6:13–22. Available from: https://doi.org/10.21037/jxym-20-121
Dixit R, et al. Diagnosis and management options in malignant pleural effusions. Lung India. 2017;34(2):160–166. Available from: https://doi.org/10.4103/0970-2113.201305
Shehata SM, Sileem AE, El-Fakharany KM. Pleural fluid CRP, LDH, and pH as predictors of successful pleurodesis in malignant pleural effusions. Egypt J Chest Dis Tuberc. 2015;64(3):593–599. Available from: https://doi.org/10.1016/j.ejcdt.2015.05.003
Dugan KC, et al. Management of Persistent Air Leaks. Chest. 2017;152(2):417–423. Available from: https://doi.org/10.1016/j.chest.2017.02.020
Feller-Kopman DJ, et al. Management of malignant pleural effusions: An official ATS/STS/STR clinical practice guideline. Am J Respir Crit Care Med. 2018;198(7):839–849. Available from: https://doi.org/10.1164/rccm.201807-1415ST
Fysh ETH, et al. Pleurodesis outcome in malignant pleural mesothelioma. Thorax. 2013;68(6):594–596. Available from: https://doi.org/10.1136/thoraxjnl-2012-203043
Hamouda D, Elsayed E, Alawady SM. Pleurodesis using bleomycin ampoules, doxycycline capsules and povidone iodine solution in patients with malignant pleural effusion in Zagazig University Hospitals. Zagazig Univ Med J. 2022;28(5):1022–1028. Available from: https://doi.org/10.21608/ZUMJ.2022.118927.2466
Ibrahim IM, et al. Povidone-iodine pleurodesis versus talc pleurodesis in preventing recurrence of malignant pleural effusion. J Cardiothorac Surg. 2015;10(1):1–6. Available from: https://doi.org/10.1186/s13019-015-0270-5
Kishi K, et al. Efficacious pleurodesis with OK-432 and doxorubicin against malignant pleural effusions. Eur Respir J. 2004;24(2):263–266. Available from: https://doi.org/10.1183/09031936.04.00137403
Kisseleva T, Brenner DA. Fibrogenesis of parenchymal organs. Proc Am Thorac Soc. 2008;5(3):338–342. Available from: https://doi.org/10.1513/pats.200711-168DR
Light RW. Pleural Diseases. 6th ed. Philadelphia: Lippincott Williams & Wilkins; 2013.
Marhana IA, Handoko AT. Hubungan nilai pH cairan pleura dengan hasil pleurodesis pada penderita efusi pleura karena keganasan. Jurnal Respirasi. 2019;3(1):1–6. Available from: https://doi.org/10.20473/jr.v3-i.1.2017.1-6
Mierzejewski M, et al. Chemical pleurodesis – A review of mechanisms involved in pleural space obliteration. Respir Res. 2019;20(1):1–16. Available from: https://doi.org/10.1186/s12931-019-1204-x
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Jurnal Profesi Medika : Jurnal Kedokteran dan Kesehatan

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright Notice
All articles submitted by the author and published in the Jurnal Profesi Medika : Jurnal Kedokteran dan Kesehatan, are fully copyrighted by the publication of Jurnal Profesi Medika : Jurnal Kedokteran dan Kesehatan under the Creative Commons Attribution-NonCommercial 4.0 International License by technically filling out the copyright transfer agreement and sending it to the publisher
Note :
The author can include in separate contractual arrangements for the non-exclusive distribution of rich versions of journal publications (for example: posting them to an institutional repository or publishing them in a book), with the acknowledgment of their initial publication in this journal.
Authors are permitted and encouraged to post their work online (for example: in an institutional repository or on their website) before and during the submission process because it can lead to productive exchanges, as well as earlier and more powerful citations of published works. (See Open Access Effects).



